Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron Prehabilitation in Endometrial Cancer
NCT06049693Phase 4Completed
- Sponsor
- National and Kapodistrian University of Athens
- Start
- Jan 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Ferrous gluconate in iron deficiency anemia (IDA) (2 arms), sponsored by National and Kapodistrian University of Athens. Primary endpoints: Number of participants with surgical site infection at 30 days and Required blood transfusions per participant and aggregated mean differences at 10 days. Started Jan 2023; status: completed.
02
Drugs
Ferrous gluconate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT06049693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06049693.